110 related articles for article (PubMed ID: 10595349)
1. Polyethyleneimine-mediated transfection to improve antisense activity of 3'-capped phosphodiester oligonucleotides.
Dheur S; Saison-Behmoaras TE
Methods Enzymol; 2000; 313():56-73. PubMed ID: 10595349
[No Abstract] [Full Text] [Related]
2. In vitro and in vivo delivery of antisense oligodeoxynucleotides using lipofection: application of antisense technique to growth suppression of experimental glioma.
Matsuno A; Nagashima T; Katayama H; Tamura A
Methods Enzymol; 2000; 313():359-72. PubMed ID: 10595366
[No Abstract] [Full Text] [Related]
3. Determination of cellular internalization of fluoresceinated oligonucleotides.
Benimetskaya L; Tonkinson J; Stein CA
Methods Enzymol; 2000; 313():287-97. PubMed ID: 10595362
[No Abstract] [Full Text] [Related]
4. Gene switching: analyzing a broad range of mutations using steric block antisense oligonucleotides.
Morcos PA
Methods Enzymol; 2000; 313():174-89. PubMed ID: 10595356
[No Abstract] [Full Text] [Related]
5. In vitro transport and delivery of antisense oligonucleotides.
Hughes J; Astriab A; Yoo H; Alahari S; Liang E; Sergueev D; Shaw BR; Juliano RL
Methods Enzymol; 2000; 313():342-58. PubMed ID: 10595365
[TBL] [Abstract][Full Text] [Related]
6. Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides.
Dheur S; Dias N; van Aerschot A; Herdewijn P; Bettinger T; Rémy JS; Hélène C; Saison-Behmoaras ET
Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):515-25. PubMed ID: 10645777
[TBL] [Abstract][Full Text] [Related]
7. Chimeric oligodeoxynucleotide analogs: chemical synthesis, purification, and molecular and cellular biology protocols.
Giles RV; Spiller DG; Tidd DM
Methods Enzymol; 2000; 313():95-135. PubMed ID: 10595351
[No Abstract] [Full Text] [Related]
8. Intracellular distribution of digoxigenin-labeled phosphorothioate oligonucleotides.
Tarrasón G; Bellido D; Eritja R; Vilaró S; Piulats J
Methods Enzymol; 2000; 313():257-68. PubMed ID: 10595360
[No Abstract] [Full Text] [Related]
9. 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) for effective antisense formation.
Morita K; Yamate K; Kurakata S; Watanabe K; Imanishi T; Koizumi M
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1619-21. PubMed ID: 14565480
[TBL] [Abstract][Full Text] [Related]
10. Preparation and application of liposome-incorporated oligodeoxynucleotides.
Tari AM
Methods Enzymol; 2000; 313():372-88. PubMed ID: 10595367
[No Abstract] [Full Text] [Related]
11. Delivery of antisense oligonucleotides to PC12 cells.
Acosta R; Montañez C; Gómez P; Cisneros B
Neurosci Res; 2002 May; 43(1):81-6. PubMed ID: 12074844
[TBL] [Abstract][Full Text] [Related]
12. Selective degradation of targeted mRNAs using partially modified oligonucleotides.
Dagle JM; Weeks DL
Methods Enzymol; 2000; 313():420-36. PubMed ID: 10595370
[No Abstract] [Full Text] [Related]
13. A two step model aimed at delivering antisense oligonucleotides in targeted cells.
Toth J; Boszormenyi I; Majer ZS; Laczko I; Malvy C; Hollosi M; Bertrand JR
Biochem Biophys Res Commun; 2002 Apr; 293(1):18-22. PubMed ID: 12054557
[TBL] [Abstract][Full Text] [Related]
14. A cytosine analog that confers enhanced potency to antisense oligonucleotides.
Flanagan WM; Wolf JJ; Olson P; Grant D; Lin KY; Wagner RW; Matteucci MD
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3513-8. PubMed ID: 10097067
[TBL] [Abstract][Full Text] [Related]
15. Use of minimally modified antisense oligonucleotides for specific inhibition of gene expression.
Uhlmann E; Peyman A; Ryte A; Schmidt A; Buddecke E
Methods Enzymol; 2000; 313():268-84. PubMed ID: 10595361
[No Abstract] [Full Text] [Related]
16. Synthesis and properties of novel antisense oligonucleotides bearing an anthraquinone moiety at an internucleotide linkage.
Miyashita T; Mori K; Shinozuka K
Nucleic Acids Symp Ser; 1999; (42):163-4. PubMed ID: 10780430
[TBL] [Abstract][Full Text] [Related]
17. The mononucleotide-dependent, nonantisense mechanism of action of phosphodiester and phosphorothioate oligonucleotides depends upon the activity of an ecto-5'-nucleotidase.
Koziolkiewicz M; Gendaszewska E; Maszewska M; Stein CA; Stec WJ
Blood; 2001 Aug; 98(4):995-1002. PubMed ID: 11493444
[TBL] [Abstract][Full Text] [Related]
18. Intrabody tissue-specific delivery of antisense conjugates in animals: ligand-linker-antisense oligomer conjugates.
Duff RJ; Deamond SF; Roby C; Zhou Y; Ts'o PO
Methods Enzymol; 2000; 313():297-321. PubMed ID: 10595363
[No Abstract] [Full Text] [Related]
19. Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides.
Pichon C; Roufaï MB; Monsigny M; Midoux P
Nucleic Acids Res; 2000 Jan; 28(2):504-12. PubMed ID: 10606649
[TBL] [Abstract][Full Text] [Related]
20. Cell-specific optimization of phosphorothioate antisense oligodeoxynucleotide delivery by cationic lipids.
Williams SA; Buzby JS
Methods Enzymol; 2000; 313():388-97. PubMed ID: 10595368
[No Abstract] [Full Text] [Related]
[Next] [New Search]
